catalog number :
MBS1497890
products full name :
Rabbit anti-human SGSH polyclonal Antibody
products short name :
[SGSH]
products name syn :
[Sulfoglucosamine sulfamidase;Sulphamidase;SGSH;HSS]
other names :
[N-sulphoglucosamine sulphohydrolase; N-sulphoglucosamine sulphohydrolase; N-sulphoglucosamine sulphohydrolase; N-sulfoglucosamine sulfohydrolase; Sulfoglucosamine sulfamidase; Sulphamidase]
products gene name :
[SGSH]
other gene names :
[SGSH; SGSH; HSS; SFMD; MPS3A; HSS]
uniprot entry name :
SPHM_HUMAN
purity :
Antigen Affinity Purified
storage stability :
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C or -80 degree C. Avoid repeated freeze.
tested application :
ELISA (EIA), Immunohistochemistry (IHC)
app notes :
Recommended dilution: IHC:1:20-1:200
image1 heading :
Immunohistochemistry (IHC)
image2 heading :
Immunohistochemistry (IHC)
other info1 :
Storage Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. Conjugate: Non-conjugated
other info2 :
Immunogen: Recombinant human N-sulphoglucosamine sulphohydrolase protein (273-502aa). Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-79741 / sc-79742
products description :
SGSH(N-sulphoglucosamine sulphohydrolase) is also named as HSS, sulphamidase and belongs to the sulfatase family. Sulfamidase is synthesized as a 62 kDa precursor protein, which is modified with mannose 6-phosphate (M6P) residues, allowing their recognition by mannose-6-phosphate receptors in the Golgi complex and ensuring transport to the endosomal/lysosomal system. It catalyzes the third step of degradation of glucosaminoglycans and is required for the degradation of heparan sulphate. Defects in SGSH are the cause of mucopolysaccharidosis type 3A (MPS3A), also known as Sanfilippo syndrome A.
ncbi acc num :
NP_000190.1
ncbi gb acc num :
NM_000199.3
ncbi mol weight :
56,695 Da
ncbi pathways :
Glycosaminoglycan Degradation Pathway (82981); Glycosaminoglycan Degradation Pathway (355); Glycosaminoglycan Metabolism Pathway (1269972); HS-GAG Degradation Pathway (1269983); Heparan Sulfate Degradation Pathway (413377); Heparan Sulfate Degradation Pathway (468270); Heparan Sulfate/heparin (HS-GAG) Metabolism Pathway (1269980); Lysosome Pathway (99052); Lysosome Pathway (96865); Metabolic Pathways (132956)
ncbi summary :
This gene encodes one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with Sanfilippo syndrome A, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
uniprot summary :
SGSH: Defects in SGSH are the cause of mucopolysaccharidosis type 3A (MPS3A); also known as Sanfilippo syndrome A. MPS3A is a severe form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life. MPS3A is characterized by earlier onset, rapid progression of symptoms and shorter survival. Belongs to the sulfatase family. Protein type: EC 3.10.1.1; Hydrolase; Glycan Metabolism - glycosaminoglycan degradation. Chromosomal Location of Human Ortholog: 17q25.3. Cellular Component: lysosomal lumen. Molecular Function: catalytic activity; metal ion binding; N-sulfoglucosamine sulfohydrolase activity; sulfuric ester hydrolase activity. Biological Process: carbohydrate metabolic process; glycosaminoglycan catabolic process; glycosaminoglycan metabolic process; proteoglycan metabolic process. Disease: Mucopolysaccharidosis, Type Iiia